Literature DB >> 15607696

Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model.

Ori Rogowski1, Itzhak Shapira, Ari Zimran, David Zeltser, Deborah Elstein, Drorit Attias, Amir Bashkin, Shlomo Berliner.   

Abstract

Patients with Gaucher disease, perhaps due to chronic storage of glycolipids, apparently harbor a subclinical or underlying inflammation. Quantification of a baseline inflammatory profile in patients with Gaucher disease is more impressive when compared with that of matched healthy controls in a systematic, automated fashion. A mean of 16 healthy controls was generated for each of 50 patients with Gaucher disease by applying variables relating to potential for inflammatory features, for example, atherothrombotic risk factors. Relative to matched controls, male patients with Gaucher disease had significant elevations in fibrinogen (312 +/- 61 vs. 244 +/- 21 mg/dl; P = 0.002), accelerated erythrocyte sedimentation rate (ESR) (21.5 +/- 16.1 vs. 7.0 +/- 1.4 mm/H; P = 0.004), and elevated high-sensitivity C-reactive protein (hs-CRP) (1.4 +/- 2.4 vs. 0.9 +/- 1.6 mg/l; P = 0.026). Comparison of female patients versus controls revealed significant elevations in fibrinogen (337 +/- 81 vs. 273 +/- 19 mg/dl; P < 0.0005) and accelerated erythrocyte sedimentation rate (33.1 +/- 22.2 vs. 15.6 +/- 3.1 mm/H; P < 0.0005). Enzyme replacement therapy for Gaucher disease did not affect these values. Comparison with the matched healthy controls highlights the true low-grade inflammatory profile in Gaucher disease. By employing information from well-matched controls, even low-grade inflammatory conditions that may have otherwise been considered "within normal limits" can be teased out. This approach is not disease-specific and can be easily applied to any acute or subacute inflammatory disease/condition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607696     DOI: 10.1016/j.bcmd.2004.08.023

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  7 in total

1.  Heart rate and microinflammation in men: a relevant atherothrombotic link.

Authors:  O Rogowski; I Shapira; A Shirom; S Melamed; S Toker; S Berliner
Journal:  Heart       Date:  2007-01-19       Impact factor: 5.994

2.  A branch retinal artery occlusion in a patient with Gaucher disease.

Authors:  Alice Bruscolini; Maria Pia Pirraglia; Lucia Restivo; Giovanni Spinucci; Alessandro Abbouda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-02       Impact factor: 3.117

3.  Oral temperature in daily life. A new look in the era of microinflammation.

Authors:  O Rogowski; I Shapira; S Toker; A Shirom; S Melamed; S Berliner
Journal:  Inflammation       Date:  2005-04       Impact factor: 4.092

4.  Long-term response in biochemical markers of bone turnover during enzyme replacement therapy in a case-series of patients with Gaucher disease type I from Northern Greece.

Authors:  E Vargiami; M Dimitriadou; M Economou; A Christoforidis; D I Zafeiriou
Journal:  Hippokratia       Date:  2016 Apr-Jun       Impact factor: 0.471

5.  Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease.

Authors:  G Altarescu; G Chicco; C Whybra; S Delgado-Sanchez; N Sharon; M Beck; D Elstein
Journal:  J Inherit Metab Dis       Date:  2008-01-05       Impact factor: 4.982

6.  Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher disease.

Authors:  Christos Sotiropoulos; George Theodorou; Constantina Repa; Theodoros Marinakis; Eugenia Verigou; Elena Solomou; Marina Karakantza; Argiris Symeonidis
Journal:  JIMD Rep       Date:  2014-10-12

7.  Optimal therapy in Gaucher disease.

Authors:  Ozlem Goker-Alpan
Journal:  Ther Clin Risk Manag       Date:  2010-07-21       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.